Cresco Labs terminates $2 bln deal to buy Columbia Care
31/07/2023 13:30
July 31 (Reuters) - Cannabis company Cresco Labs CL.CD said on Monday it has terminated the $2 billion deal to buy rival Columbia Care Inc CCHW.NLB . (Reporting by Arshreet Singh in Bengaluru; Editing by Krishna Chandra Eluri) ((Arshreet.Singh@thomsonreuters.com; Twitter: https://twitter.com/Arshreets;))
Recent news on Cresco Labs
See all newsCresco Labs Q2 revenue beats estimates
Brief: Cresco Labs Closes Us$50 Million Revolving Credit Facility With Needham Bank
Brief: Cresco Labs Provides Update On Texas License Previously Awarded By Texas Department Of Public Safety
Cresco Labs Q1 revenue falls less than expected
Brief: Cannabis Teamsters End 20-Day Strike At Sunnyside Dispensary With New Contract